Table 3: Distribution of ACP1 phenotypes in relation to age at the onset of T2D.
| ACP1 phenotype % proportion | Total N° | ||||||
|---|---|---|---|---|---|---|---|
| A | B | BA | CA | CB | |||
| T2D | All (α) | 5.8 | 40.9 | 37.2 | 7.3 | 8.8 | 274 |
| Aging 67 yrs or less (β) | 6.0 | 42.7 | 36.7 | 7.3 | 7.8 | 248 | |
| Aging more than 67 yrs (γ) | 3.8 | 23.1 | 42.3 | 7.7 | 23.1 | 26 | |
| Controls (δ) | 10.5 | 42.4 | 35.8 | 5.3 | 6.1 | 380 | |
| Chi square test of independence | χ2 | df | p | ||||
|
All ACP1 phenotypes α vs. δ β vs. γ β vs. δ γ vs. δ |
6.961 9.350 4.796 13.701 |
4 4 4 4 |
0.138 0.053 0.309 0.309 |
||||
|
B phenotype vs. other phenotypes β vs. δ γ vs. δ |
3.653 3.879 |
1 1 |
0.052 0.048 |
||||
|
CB phenotype vs. other phenotypes β vs. γ δ vs. γ |
5.522 8.222 |
1 1 |
0.018 0.004 |
||||
|
B vs. CB vs. other phenotypes β vs. γ δ vs. γ |
10.370 12.100 |
2 2 |
0.005 0.002 |
||||